3.4 Environmental Sampling Excursions, Trend Analysis, and Remediation Protocols

Definition of an Environmental Excursion

An environmental excursion is an out-of-specification (OOS) event indicating a loss of environmental control. Under USP <797>, an excursion is triggered when:

1. Non-viable particle concentrations exceed ISO 14644-1 limits during dynamic testing.
2. Viable air CFU counts exceed action levels (> 1 in ISO 5, > 10 in ISO 7, > 100 in ISO 8).
3. Surface microbial CFU counts exceed action levels (> 3 in ISO 5, > 5 in ISO 7, > 50 in ISO 8).
4. A facility-defined trigger is met. For example, an SOP may treat any recovery of an organism it lists as objectionable as an excursion. The current chapter does not require this, but the 2008 chapter did, and many facilities kept the rule.

Microbial Identification Requirements

When an air or surface result exceeds its action level, USP <797> requires an attempt to identify the recovered organisms to the genus level, with a microbiologist's help. The corrective action plan must depend on both the count and the organism. Identification below the action level is not required, but it is valuable in any investigation.

Why Genus Identification Matters

Knowing whether an organism is Bacillus, Staphylococcus, Pseudomonas, or Aspergillus provides vital forensic intelligence regarding the source of contamination:

• Human Source (e.g., Staphylococcus epidermidis, Micrococcus luteus): Points directly to improper garbing, exposed skin, poor hand hygiene, or personnel touch contamination.
• Water/Plumbing Source (e.g., Pseudomonas aeruginosa, Burkholderia cepacia, Serratia marcescens): Points to sink splashback, stagnant drain traps, leaking HVAC coils, or wet mops.
• Environmental/Airborne Spore Source (e.g., Bacillus species, Aspergillus, Penicillium): Points to cardboard introduction, unsealed construction, damaged HEPA filters, or failure to apply sporicidal disinfectants.

Objectionable and Highly Pathogenic Organisms

Many facility SOPs treat recovery of Gram-negative bacilli, coagulase-positive staphylococci (Staphylococcus aureus), or any mold or yeast as objectionable regardless of count, which carries forward the 2008 chapter's rule. Typical SOP responses are stopping compounding in the affected area, a formal CAPA, and notifying clinicians if CSPs made during the period were distributed.

Step-by-Step Excursion Remediation Workflow

[Excursion Identified]
         │
         ▼
[1. Immediate Containment] ──► Quarantine affected PEC / Halt compounding
         │
         ▼
[2. Microbial Identification] ──► Identify to genus level; assess pathogenicity
         │
         ▼
[3. Root Cause Analysis] ──► Evaluate HVAC, cleaning logs, personnel, materials
         │
         ▼
[4. Comprehensive Remediation] ──► Triple cleaning with sporicidal disinfectant
         │
         ▼
[5. Re-Sampling] ──► Active air & surface sampling under dynamic conditions
         │
         ▼
[6. Retrospective Risk Evaluation] ──► Evaluate integrity of CSPs made in window

Comprehensive Cleaning and Disinfection Protocol

Remediation of an excursion requires a rigorous triple-cleaning decontamination protocol:

1. Detergent Cleaning: Wash all surfaces with a sterile neutral detergent and purified water to strip organic biofilms and particulate soils.
2. Disinfection: Apply a sterile EPA-registered disinfectant (e.g., quaternary ammonium compound or phenolic) with verified contact time.
3. Sporicidal Application: Saturate all walls, ceilings, fixtures, and PEC interiors with a sterile sporicidal agent (e.g., hydrogen peroxide/peracetic acid blend or sodium hypochlorite) for the full manufacturer-mandated dwell time.
4. Sterile 70% IPA Rinse: Remove corrosive or sticky chemical residues from stainless steel surfaces.

Retrospective Patient Risk Evaluation

The Designated Person must evaluate all CSPs prepared during the excursion window (from the date of sampling until identification of the excursion). If high-risk or pathogenic organisms were present, the pharmacy must immediately initiate product quarantine, evaluate patient recall protocols, and notify clinical providers of potential microbial exposure.

---

Clearance Criteria and Dynamic Re-sampling

Compounding operations cannot resume simply because cleaning was completed. Formal facility clearance requires documented dynamic re-sampling:

1. Environmental Stabilization: The HVAC system must run continuously for several hours after cleaning to purge chemical vapors and re-establish pressure cascades.
2. Dynamic Re-sampling Protocol: Technicians execute comprehensive viable active air sampling, total non-viable particle counts, and surface contact plate sampling under simulated dynamic compounding conditions.
3. Clearance Benchmarks: All sample locations must yield zero objectionable organisms, and all numerical CFU and non-viable particle counts must fall comfortably below pharmacopeial action levels.
4. Formal Sign-off: The Designated Person must review the complete CAPA investigation package, verify microbiological laboratory clearance reports, and execute a formal written release before any patient compounding resumes.

---

Statistical Trend Analysis and Quality Assurance Control Charting

Modern quality systems do not wait for an action-level breach to occur. USP <797> requires regular review of sampling data to detect trends, together with personnel data such as training records, observations and competency results. Facilities utilize Statistical Process Control (SPC) tools, such as Shewhart control charts and cumulative sum (CUSUM) analyses, to evaluate bioburden trajectory over time.

Establishing Alert Levels

Action levels are defined by USP <797>. The chapter does not set alert levels, but USP <1116> describes them, and many facilities set their own (typically set at $50\%$ of the regulatory action level or based on 2 standard deviations above baseline bioburden):

• ISO Class 7 Surface Alert Level: $\ge 3\,\text{CFU}$ (triggers internal sanitization review before reaching the action level of $> 5\,\text{CFU}$).
• ISO Class 8 Surface Alert Level: $\ge 25\,\text{CFU}$ (triggers gowning audit before breaching $> 50\,\text{CFU}$).

Identifying Adverse Patterns

A trend is defined by:

• Three consecutive sampling events demonstrating a steady upward drift in CFU counts, even if all results remain below official action levels.
• Repeated recovery of the same microbial genus (e.g., recurring Micrococcus or Bacillus) over multiple cycles, indicating persistent biofilm formation or ineffective sanitizers.
• Seasonal bioburden spikes: Tracking seasonal transitions enables compounding leadership to proactively increase sporicidal application frequencies and replace HVAC intake pre-filters before cleanroom excursions compromise sterile compounding safety.